It really looks as though the market is expecting nothing in the way of a positive mention of Zola in the soon-to-be-released quarterly and very few are willing to bet against that at present. If that's the way it transpires then I guess we can look forward to a further slip into the mid 6s. Certainly a bargain if your crystal ball tells you that Ringwood has the goods.
If no spodumene, page-52
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
